FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Int J Mol Sci / Improvement of the Chondrocyte-Specific Phenotype upon Equin...
International journal of molecular sciences2018; 19(2); 435; doi: 10.3390/ijms19020435

Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index.

Abstract: Articular cartilage is a tissue characterized by its poor intrinsic capacity for self-repair. This tissue is frequently altered upon trauma or in osteoarthritis (OA), a degenerative disease that is currently incurable. Similar musculoskeletal disorders also affect horses and OA incurs considerable economic loss for the equine sector. In the view to develop new therapies for humans and horses, significant progress in tissue engineering has led to the emergence of new generations of cartilage therapy. Matrix-associated autologous chondrocyte implantation is an advanced 3D cell-based therapy that holds promise for cartilage repair. This study aims to improve the autologous chondrocyte implantation technique by using equine mesenchymal stem cells (MSCs) from bone marrow differentiated into chondrocytes that can be implanted in the chondral lesion. The optimized protocol relies on culture under hypoxia within type I/III collagen sponges. Here, we explored three parameters that influence MSC differentiation: culture times, growth factors and RNA interference strategies. Our results suggest first that an increase in culture time from 14 to 28 or 42 days lead to a sharp increase in the expression of chondrocyte markers, notably type II collagen (especially the IIB isoform), along with a concomitant decrease in HtrA1 expression. Nevertheless, the expression of type I collagen also increased with longer culture times. Second, regarding the growth factor cocktail, TGF-β3 alone showed promising result but the previously tested association of BMP-2 and TGF-β1 better limits the expression of type I collagen. Third, RNA interference targeting as well as mRNA led to a more significant knockdown, compared with a conventional strategy targeting alone. This chondrogenic differentiation strategy showed a strong increase in the : mRNA ratio in the chondrocytes derived from equine bone marrow MSCs, this ratio being considered as an index of the functionality of cartilage. These data provide evidence of a more stable chondrocyte phenotype when combining and siRNAs associated to a longer culture time in the presence of BMP-2 and TGF-β1, opening new opportunities for preclinical trials in the horse. In addition, because the horse is an excellent model for human articular cartilage disorders, the equine therapeutic approach developed here can also serve as a preclinical step for human medicine.
Get Full Text
Publication Date: 2018-02-01 PubMed ID: 29389887PubMed Central: PMC5855657DOI: 10.3390/ijms19020435Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research centers on improving methods for repairing cartilage damage, specifically in horses but also potentially in humans. The researchers focused on three parameters – culture time, growth factors, and RNA interference strategies – to optimize chondrocyte differentiation from equine mesenchymal stem cells, to be used in an advanced 3D cell-based therapy aimed at repairing cartilage.

Objective of the Study

  • The main aim of the study was to devise a better method for repairing damaged articular cartilage, which currently has limited capacity for self-repair. The target of this research were equines suffering from osteoarthritis, due to the significant economic impact this condition has on the horse industry. Improvements found within this research could also be applied to humans suffering from similar conditions.

Research Design and Methods

  • The researchers adapted the advanced 3D cell-based therapy called ‘matrix-associated autologous chondrocyte implantation’ for this study. The therapy uses mesenchymal stem cells (MSCs) from equine bone marrow, which are differentiated into chondrocytes and implanted into the cartilage lesion. The procedure was optimized under hypoxia within type I/III collagen sponges.
  • Three parameters influencing MSC differentiation were explored: culture times, growth factors, and RNA interference strategies. The culture times tested were 14, 28 and 42 days. Positive impact was noted with an increase in culture times, with a marked increase in chondrocyte marker expression and a decrease in HtrA1 expression observed.
  • For growth factors, TGF-β3 showed promising results, but the combination of BMP-2 and TGF-β1 was found to significantly limit the expression of type I collagen, suggesting a more optimal outcome.
  • RNA interference targeting combination strategies led to a more impactful knockdown compared to using conventional strategies. This differentiation strategy resulted in a significant increase in the IIB:IIB mRNA ratio—an index of cartilage functionality—in the chondrocytes derived from the equine bone marrow MSCs.

Conclusion and Implications

  • The research data suggested a more stable chondrocyte phenotype when longer culture times were combined with BMP-2 and TGF-β1, and when RNA interference strategies were utilized. This could open new opportunities for preclinical trials in equine subjects.
  • As the horse is an effective model for studying human articular cartilage disorders, the therapeutic approaches developed and proven in the equine model could also serve as preclinical steps for human medicine, substantially benefiting the research and treatment of human articular cartilage disorders.

Cite This Article

APA
Branly T, Contentin R, Desancé M, Jacquel T, Bertoni L, Jacquet S, Mallein-Gerin F, Denoix JM, Audigié F, Demoor M, Galéra P. (2018). Improvement of the Chondrocyte-Specific Phenotype upon Equine Bone Marrow Mesenchymal Stem Cell Differentiation: Influence of Culture Time, Transforming Growth Factors and Type I Collagen siRNAs on the Differentiation Index. Int J Mol Sci, 19(2), 435. https://doi.org/10.3390/ijms19020435

Publication

International journal of molecular sciences
ISSN: 1422-0067
NlmUniqueID: 101092791
Country: Switzerland
Language: English
Volume: 19
Issue: 2
PII: 435

Researcher Affiliations

Branly, Thomas
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. tbranly@gmail.com.
Contentin, Romain
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. romaincontentin@hotmail.fr.
Desancé, Mélanie
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. melanie359@hotmail.fr.
Jacquel, Thibaud
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. jacquel.thibaud@gmail.com.
Bertoni, Lélia
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430 Goustranville, France. lelia.bertoni@vet-alfort.fr.
Jacquet, Sandrine
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430 Goustranville, France. sandrine.jacquet@vet-alfort.fr.
Mallein-Gerin, Frédéric
  • Institute for Biology and Chemistry of Proteins, CNRS, UMR 5305 Laboratory of Tissue Biology and Therapeutic Engineering, Université Claude Bernard-Lyon 1, Université de Lyon, 69367 Lyon CEDEX 07, France. f.mallein-gerin@ibcp.fr.
Denoix, Jean-Marie
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430 Goustranville, France.
Audigié, Fabrice
  • Center of Imaging and Research on Locomotor Affections in Equines, Ecole Vétérinaire d'Alfort, Université Paris-Est, 14430 Goustranville, France. fabrice.audigie@vet-alfort.fr.
Demoor, Magali
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. magali.demoor@unicaen.fr.
Galéra, Philippe
  • Normandie Univ, UNICAEN, BIOTARGEN, 14000 Caen, France. philippe.galera@unicaen.fr.

MeSH Terms

  • Animals
  • Cell Culture Techniques / methods
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Chondrocytes / cytology
  • Chondrocytes / metabolism
  • Chondrogenesis / genetics
  • Collagen Type I / genetics
  • Horses
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Osteoarthritis / therapy
  • Phenotype
  • RNA Interference
  • RNA, Small Interfering / genetics
  • Tissue Engineering / methods
  • Transforming Growth Factors / genetics

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 51 references
  1. Aigner T, Stöve J. Collagens--major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair.. Adv Drug Deliv Rev 2003 Nov 28;55(12):1569-93.
    doi: 10.1016/j.addr.2003.08.009pubmed: 14623402google scholar: lookup
  2. Sandell LJ, Morris N, Robbins JR, Goldring MB. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: differential expression of the amino-propeptide.. J Cell Biol 1991 Sep;114(6):1307-19.
    doi: 10.1083/jcb.114.6.1307pmc: PMC2289128pubmed: 1894696google scholar: lookup
  3. Sandell LJ, Nalin AM, Reife RA. Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development.. Dev Dyn 1994 Feb;199(2):129-40.
    doi: 10.1002/aja.1001990206pubmed: 8204907google scholar: lookup
  4. Perrier E, Ronzière MC, Bareille R, Pinzano A, Mallein-Gerin F, Freyria AM. Analysis of collagen expression during chondrogenic induction of human bone marrow mesenchymal stem cells.. Biotechnol Lett 2011 Oct;33(10):2091-101.
    doi: 10.1007/s10529-011-0653-1pubmed: 21660579google scholar: lookup
  5. Heinonen J, Taipaleenmäki H, Roering P, Takatalo M, Harkness L, Sandholm J, Uusitalo-Järvinen H, Kassem M, Kiviranta I, Laitala-Leinonen T, Säämänen AM. Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes.. Osteoarthritis Cartilage 2011 Aug;19(8):1026-35.
    doi: 10.1016/j.joca.2011.04.016pubmed: 21624478google scholar: lookup
  6. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture.. Cell 1978 Dec;15(4):1313-21.
    doi: 10.1016/0092-8674(78)90056-9pubmed: 729001google scholar: lookup
  7. Lee DA, Bentley G, Archer CW. The control of cell division in articular chondrocytes.. Osteoarthritis Cartilage 1993 Apr;1(2):137-46.
    doi: 10.1016/S1063-4584(05)80029-9pubmed: 8886090google scholar: lookup
  8. Gelse K, Pöschl E, Aigner T. Collagens--structure, function, and biosynthesis.. Adv Drug Deliv Rev 2003 Nov 28;55(12):1531-46.
    doi: 10.1016/j.addr.2003.08.002pubmed: 14623400google scholar: lookup
  9. Chamberland A, Wang E, Jones AR, Collins-Racie LA, LaVallie ER, Huang Y, Liu L, Morris EA, Flannery CR, Yang Z. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo.. J Biol Chem 2009 Oct 2;284(40):27352-9.
    doi: 10.1074/jbc.M109.037051pmc: PMC2785663pubmed: 19657146google scholar: lookup
  10. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins.. Development 2004 Mar;131(5):1041-53.
    doi: 10.1242/dev.00999pubmed: 14973287google scholar: lookup
  11. Demoor M, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Fabre H, Lafont J, Denoix JM, Audigié F, Mallein-Gerin F, Legendre F, Galera P. Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction.. Biochim Biophys Acta 2014 Aug;1840(8):2414-40.
    doi: 10.1016/j.bbagen.2014.02.030pubmed: 24608030google scholar: lookup
  12. Aigner T, Cook JL, Gerwin N, Glasson SS, Laverty S, Little CB, McIlwraith W, Kraus VB. Histopathology atlas of animal model systems - overview of guiding principles.. Osteoarthritis Cartilage 2010 Oct;18 Suppl 3:S2-6.
    doi: 10.1016/j.joca.2010.07.013pubmed: 20864020google scholar: lookup
  13. Malda J, Benders KE, Klein TJ, de Grauw JC, Kik MJ, Hutmacher DW, Saris DB, van Weeren PR, Dhert WJ. Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles.. Osteoarthritis Cartilage 2012 Oct;20(10):1147-51.
    doi: 10.1016/j.joca.2012.06.005pubmed: 22781206google scholar: lookup
  14. Perkins NR, Reid SW, Morris RS. Profiling the New Zealand Thoroughbred racing industry. 2. Conditions interfering with training and racing.. N Z Vet J 2005 Feb;53(1):69-76.
    doi: 10.1080/00480169.2005.36471pubmed: 15731837google scholar: lookup
  15. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.. N Engl J Med 1994 Oct 6;331(14):889-95.
    doi: 10.1056/NEJM199410063311401pubmed: 8078550google scholar: lookup
  16. Brittberg M. Autologous chondrocyte transplantation.. Clin Orthop Relat Res 1999 Oct;(367 Suppl):S147-55.
    doi: 10.1097/00003086-199910001-00016pubmed: 10546643google scholar: lookup
  17. Danišovič Ľ, Boháč M, Zamborský R, Oravcová L, Provazníková Z, Csöbönyeiová M, Varga I. Comparative analysis of mesenchymal stromal cells from different tissue sources in respect to articular cartilage tissue engineering.. Gen Physiol Biophys 2016 Apr;35(2):207-14.
    doi: 10.4149/gpb_2015044pubmed: 26891275google scholar: lookup
  18. Delorme B, Ringe J, Pontikoglou C, Gaillard J, Langonné A, Sensebé L, Noël D, Jorgensen C, Häupl T, Charbord P. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity.. Stem Cells 2009 May;27(5):1142-51.
    doi: 10.1002/stem.34pubmed: 19418444google scholar: lookup
  19. Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells.. Oncogene 2004 Sep 20;23(43):7150-60.
    doi: 10.1038/sj.onc.1207930pubmed: 15378075google scholar: lookup
  20. Marlovits S, Aldrian S, Tichy B, Albrecht C, Nürnberger S. [Biomaterial for autologous chondrocyte transplantation].. Orthopade 2009 Nov;38(11):1045-52.
    doi: 10.1007/s00132-009-1494-7pubmed: 19789853google scholar: lookup
  21. Murphy MK, Huey DJ, Hu JC, Athanasiou KA. TGF-β1, GDF-5, and BMP-2 stimulation induces chondrogenesis in expanded human articular chondrocytes and marrow-derived stromal cells.. Stem Cells 2015 Mar;33(3):762-73.
    doi: 10.1002/stem.1890pubmed: 25377511google scholar: lookup
  22. Kafienah W, Mistry S, Dickinson SC, Sims TJ, Learmonth I, Hollander AP. Three-dimensional cartilage tissue engineering using adult stem cells from osteoarthritis patients.. Arthritis Rheum 2007 Jan;56(1):177-87.
    doi: 10.1002/art.22285pubmed: 17195220google scholar: lookup
  23. Ronzière MC, Perrier E, Mallein-Gerin F, Freyria AM. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells.. Biomed Mater Eng 2010;20(3):145-58.
    pubmed: 20930322doi: 10.3233/bme-2010-0626google scholar: lookup
  24. Legendre F, Ollitrault D, Hervieu M, Baugé C, Maneix L, Goux D, Chajra H, Mallein-Gerin F, Boumediene K, Galera P, Demoor M. Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with bone morphogenetic protein-2 under hypoxia.. Tissue Eng Part C Methods 2013 Jul;19(7):550-67.
    doi: 10.1089/ten.tec.2012.0508pubmed: 23270543google scholar: lookup
  25. Legendre F, Ollitrault D, Gomez-Leduc T, Bouyoucef M, Hervieu M, Gruchy N, Mallein-Gerin F, Leclercq S, Demoor M, Galéra P. Enhanced chondrogenesis of bone marrow-derived stem cells by using a combinatory cell therapy strategy with BMP-2/TGF-β1, hypoxia, and COL1A1/HtrA1 siRNAs.. Sci Rep 2017 Jun 13;7(1):3406.
    doi: 10.1038/s41598-017-03579-ypmc: PMC5469741pubmed: 28611369google scholar: lookup
  26. Ollitrault D, Legendre F, Drougard C, Briand M, Benateau H, Goux D, Chajra H, Poulain L, Hartmann D, Vivien D, Shridhar V, Baldi A, Mallein-Gerin F, Boumediene K, Demoor M, Galera P. BMP-2, hypoxia, and COL1A1/HtrA1 siRNAs favor neo-cartilage hyaline matrix formation in chondrocytes.. Tissue Eng Part C Methods 2015 Feb;21(2):133-47.
    doi: 10.1089/ten.tec.2013.0724pmc: PMC4313417pubmed: 24957638google scholar: lookup
  27. Branly T, Bertoni L, Contentin R, Rakic R, Gomez-Leduc T, Desancé M, Hervieu M, Legendre F, Jacquet S, Audigié F, Denoix JM, Demoor M, Galéra P. Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1.. Stem Cell Rev Rep 2017 Oct;13(5):611-630.
    doi: 10.1007/s12015-017-9748-ypubmed: 28597211google scholar: lookup
  28. Dahlin RL, Ni M, Meretoja VV, Kasper FK, Mikos AG. TGF-β3-induced chondrogenesis in co-cultures of chondrocytes and mesenchymal stem cells on biodegradable scaffolds.. Biomaterials 2014 Jan;35(1):123-32.
    doi: 10.1016/j.biomaterials.2013.09.086pmc: PMC3844679pubmed: 24125773google scholar: lookup
  29. Abbott RD, Kimmerling EP, Cairns DM, Kaplan DL. Silk as a Biomaterial to Support Long-Term Three-Dimensional Tissue Cultures.. ACS Appl Mater Interfaces 2016 Aug 31;8(34):21861-8.
    doi: 10.1021/acsami.5b12114pubmed: 26849288google scholar: lookup
  30. Adamson ED, Ayers SE. The localization and synthesis of some collagen types in developing mouse embryos.. Cell 1979 Apr;16(4):953-65.
    doi: 10.1016/0092-8674(79)90110-7pubmed: 455457google scholar: lookup
  31. Barsh GS, Byers PH. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.. Proc Natl Acad Sci U S A 1981 Aug;78(8):5142-6.
    doi: 10.1073/pnas.78.8.5142pmc: PMC320349pubmed: 6946461google scholar: lookup
  32. de Wet WJ, Chu ML, Prockop DJ. The mRNAs for the pro-alpha 1(I) and pro-alpha 2(I) chains of type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady state ratios of the two mRNAs.. J Biol Chem 1983 Dec 10;258(23):14385-9.
    pubmed: 6689020
  33. Galéra P, Park RW, Ducy P, Mattéi MG, Karsenty G. c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis.. J Biol Chem 1996 Aug 30;271(35):21331-9.
    doi: 10.1074/jbc.271.35.21331pubmed: 8702912google scholar: lookup
  34. Rosová I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.. Stem Cells 2008 Aug;26(8):2173-82.
    doi: 10.1634/stemcells.2007-1104pmc: PMC3017477pubmed: 18511601google scholar: lookup
  35. Grayson WL, Zhao F, Bunnell B, Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.. Biochem Biophys Res Commun 2007 Jul 6;358(3):948-53.
    doi: 10.1016/j.bbrc.2007.05.054pubmed: 17521616google scholar: lookup
  36. Kanichai M, Ferguson D, Prendergast PJ, Campbell VA. Hypoxia promotes chondrogenesis in rat mesenchymal stem cells: a role for AKT and hypoxia-inducible factor (HIF)-1alpha.. J Cell Physiol 2008 Sep;216(3):708-15.
    doi: 10.1002/jcp.21446pubmed: 18366089google scholar: lookup
  37. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival.. Genes Dev 2001 Nov 1;15(21):2865-76.
    pmc: PMC312800pubmed: 11691837doi: 10.1101/gad.934301google scholar: lookup
  38. Markway BD, Cho H, Johnstone B. Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes.. Arthritis Res Ther 2013 Aug 21;15(4):R92.
    doi: 10.1186/ar4272pmc: PMC3979022pubmed: 23965235google scholar: lookup
  39. Brittberg M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure.. Am J Sports Med 2010 Jun;38(6):1259-71.
    doi: 10.1177/0363546509346395pubmed: 19966108google scholar: lookup
  40. Ciuffreda MC, Malpasso G, Musarò P, Turco V, Gnecchi M. Protocols for in vitro Differentiation of Human Mesenchymal Stem Cells into Osteogenic, Chondrogenic and Adipogenic Lineages.. Methods Mol Biol 2016;1416:149-58.
    pubmed: 27236670doi: 10.1007/978-1-4939-3584-0_8google scholar: lookup
  41. Yang W, Both SK, van Osch GJ, Wang Y, Jansen JA, Yang F. Effects of in vitro chondrogenic priming time of bone-marrow-derived mesenchymal stromal cells on in vivo endochondral bone formation.. Acta Biomater 2015 Feb;13:254-65.
    doi: 10.1016/j.actbio.2014.11.029pubmed: 25463490google scholar: lookup
  42. Farrell MJ, Fisher MB, Huang AH, Shin JI, Farrell KM, Mauck RL. Functional properties of bone marrow-derived MSC-based engineered cartilage are unstable with very long-term in vitro culture.. J Biomech 2014 Jun 27;47(9):2173-82.
    doi: 10.1016/j.jbiomech.2013.10.030pmc: PMC3995895pubmed: 24239005google scholar: lookup
  43. Kim YI, Ryu JS, Yeo JE, Choi YJ, Kim YS, Ko K, Koh YG. Overexpression of TGF-β1 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cells.. Biochem Biophys Res Commun 2014 Aug 8;450(4):1593-9.
    doi: 10.1016/j.bbrc.2014.07.045pubmed: 25035928google scholar: lookup
  44. Gómez-Leduc T, Hervieu M, Legendre F, Bouyoucef M, Gruchy N, Poulain L, de Vienne C, Herlicoviez M, Demoor M, Galéra P. Chondrogenic commitment of human umbilical cord blood-derived mesenchymal stem cells in collagen matrices for cartilage engineering.. Sci Rep 2016 Sep 8;6:32786.
    doi: 10.1038/srep32786pmc: PMC5015060pubmed: 27604951google scholar: lookup
  45. Barile FA, Siddiqi ZE, Ripley-Rouzier C, Bienkowski RS. Effects of puromycin and hydroxynorvaline on net production and intracellular degradation of collagen in human fetal lung fibroblasts.. Arch Biochem Biophys 1989 Apr;270(1):294-301.
    doi: 10.1016/0003-9861(89)90031-3pubmed: 2494943google scholar: lookup
  46. Gotkin MG, Ripley CR, Lamande SR, Bateman JF, Bienkowski RS. Intracellular trafficking and degradation of unassociated proalpha2 chains of collagen type I.. Exp Cell Res 2004 Jun 10;296(2):307-16.
    doi: 10.1016/j.yexcr.2004.01.029pubmed: 15149860google scholar: lookup
  47. Veitia RA, Bottani S, Birchler JA. Cellular reactions to gene dosage imbalance: genomic, transcriptomic and proteomic effects.. Trends Genet 2008 Aug;24(8):390-7.
    doi: 10.1016/j.tig.2008.05.005pubmed: 18585818google scholar: lookup
  48. Rodríguez JP, Montecinos L, Ríos S, Reyes P, Martínez J. Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation.. J Cell Biochem 2000 Sep 14;79(4):557-65.
    doi: 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-Hpubmed: 10996846google scholar: lookup
  49. Essex S, Navarro G, Sabhachandani P, Chordia A, Trivedi M, Movassaghian S, Torchilin VP. Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors.. Gene Ther 2015 Mar;22(3):257-266.
    doi: 10.1038/gt.2014.97pmc: PMC4352110pubmed: 25354685google scholar: lookup
  50. Xu J, Li J, Lin S, Wu T, Huang H, Zhang K, Sun Y, Yeung K.W.K., Li G, Bian L. Nanocarrier-mediated codelivery of small molecular drugs and siRNA to enhance chondrogenic differentiation and suppress hypertrophy of human mesenchymal stem cells.. Adv. Funct. Mater. 2016;26:2463–2472.
    doi: 10.1002/adfm.201504070google scholar: lookup
  51. Aubert-Foucher E, Mayer N, Pasdeloup M, Pagnon A, Hartmann D, Mallein-Gerin F. A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein.. Matrix Biol 2014 Feb;34:80-8.
    doi: 10.1016/j.matbio.2013.09.001pubmed: 24055103google scholar: lookup

Citations

This article has been cited 14 times.
  1. Tejpal Singh HS, Aminuddin AA, Pang KL, Ekeuku SO, Chin KY. The Role of Tocotrienol in Arthritis Management-A Scoping Review of Literature. Pharmaceuticals (Basel) 2023 Mar 2;16(3).
    doi: 10.3390/ph16030385pubmed: 36986484google scholar: lookup
  2. Jammes M, Contentin R, Cassé F, Galéra P. Equine osteoarthritis: Strategies to enhance mesenchymal stromal cell-based acellular therapies. Front Vet Sci 2023;10:1115774.
    doi: 10.3389/fvets.2023.1115774pubmed: 36846261google scholar: lookup
  3. Bourdon B, Contentin R, Cassé F, Maspimby C, Oddoux S, Noël A, Legendre F, Gruchy N, Galéra P. Marine Collagen Hydrolysates Downregulate the Synthesis of Pro-Catabolic and Pro-Inflammatory Markers of Osteoarthritis and Favor Collagen Production and Metabolic Activity in Equine Articular Chondrocyte Organoids. Int J Mol Sci 2021 Jan 8;22(2).
    doi: 10.3390/ijms22020580pubmed: 33430111google scholar: lookup
  4. Lo Monaco M, Gervois P, Beaumont J, Clegg P, Bronckaers A, Vandeweerd JM, Lambrichts I. Therapeutic Potential of Dental Pulp Stem Cells and Leukocyte- and Platelet-Rich Fibrin for Osteoarthritis. Cells 2020 Apr 15;9(4).
    doi: 10.3390/cells9040980pubmed: 32326610google scholar: lookup
  5. Contentin R, Demoor M, Concari M, Desancé M, Audigié F, Branly T, Galéra P. Comparison of the Chondrogenic Potential of Mesenchymal Stem Cells Derived from Bone Marrow and Umbilical Cord Blood Intended for Cartilage Tissue Engineering. Stem Cell Rev Rep 2020 Feb;16(1):126-143.
    doi: 10.1007/s12015-019-09914-2pubmed: 31745710google scholar: lookup
  6. Gale AL, Mammone RM, Dodson ME, Linardi RL, Ortved KF. The effect of hypoxia on chondrogenesis of equine synovial membrane-derived and bone marrow-derived mesenchymal stem cells. BMC Vet Res 2019 Jun 14;15(1):201.
    doi: 10.1186/s12917-019-1954-1pubmed: 31200719google scholar: lookup
  7. Bertoni L, Branly T, Jacquet S, Desancé M, Desquilbet L, Rivory P, Hartmann DJ, Denoix JM, Audigié F, Galéra P, Demoor M. Intra-Articular Injection of 2 Different Dosages of Autologous and Allogeneic Bone Marrow- and Umbilical Cord-Derived Mesenchymal Stem Cells Triggers a Variable Inflammatory Response of the Fetlock Joint on 12 Sound Experimental Horses. Stem Cells Int 2019;2019:9431894.
    doi: 10.1155/2019/9431894pubmed: 31191689google scholar: lookup
  8. Desancé M, Contentin R, Bertoni L, Gomez-Leduc T, Branly T, Jacquet S, Betsch JM, Batho A, Legendre F, Audigié F, Galéra P, Demoor M. Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy. Int J Mol Sci 2018 Feb 10;19(2).
    doi: 10.3390/ijms19020537pubmed: 29439436google scholar: lookup
  9. Contentin R, Jehl C, Commenchail K, Legendre F, Galéra P, Cassé F, Demoor M. Mechanical Stimulation of Equine Bone Marrow Mesenchymal Stromal Cell-Derived Cartilage-Like In Vitro Model Triggers Osteoarthritis Features. ACS Biomater Sci Eng 2025 Jul 14;11(7):4153-4165.
    doi: 10.1021/acsbiomaterials.5c00500pubmed: 40512481google scholar: lookup
  10. Jeannerat A, Peneveyre C, Jaccoud S, Philippe V, Scaletta C, Hirt-Burri N, Abdel-Sayed P, Martin R, Applegate LA, Pioletti DP, Laurent A. Banked Primary Progenitor Cells for Allogeneic Intervertebral Disc (IVD) Therapy: Preclinical Qualification and Functional Optimization within a Cell Spheroid Formulation Process. Pharmaceutics 2024 Sep 29;16(10).
    doi: 10.3390/pharmaceutics16101274pubmed: 39458605google scholar: lookup
  11. Voga M. Modulation of Canine Adipose-Derived Mesenchymal Stem/Medicinal Signalling Cells with Ascorbic Acid: Effect on Proliferation and Chondrogenic Differentiation on Standard Plastic and Silk Fibroin Surfaces. Bioengineering (Basel) 2024 May 20;11(5).
    doi: 10.3390/bioengineering11050513pubmed: 38790380google scholar: lookup
  12. Jammes M, Cassé F, Velot E, Bianchi A, Audigié F, Contentin R, Galéra P. Pro-Inflammatory Cytokine Priming and Purification Method Modulate the Impact of Exosomes Derived from Equine Bone Marrow Mesenchymal Stromal Cells on Equine Articular Chondrocytes. Int J Mol Sci 2023 Sep 16;24(18).
    doi: 10.3390/ijms241814169pubmed: 37762473google scholar: lookup
  13. Jammes M, Contentin R, Audigié F, Cassé F, Galéra P. Effect of pro-inflammatory cytokine priming and storage temperature of the mesenchymal stromal cell (MSC) secretome on equine articular chondrocytes. Front Bioeng Biotechnol 2023;11:1204737.
    doi: 10.3389/fbioe.2023.1204737pubmed: 37720315google scholar: lookup
  14. Contentin R, Jammes M, Bourdon B, Cassé F, Bianchi A, Audigié F, Branly T, Velot É, Galéra P. Bone Marrow MSC Secretome Increases Equine Articular Chondrocyte Collagen Accumulation and Their Migratory Capacities. Int J Mol Sci 2022 May 21;23(10).
    doi: 10.3390/ijms23105795pubmed: 35628604google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.